Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Dae Won Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8785-4508; OpenAlex author ID A5101615430. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
55
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 4 papers · 2024: 2 papers · 2025: 4 papers · 2026: 1 paper

Papers 13

  1. Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment. Co-author DOI 10.1200/po-25-00807↗
  2. Early Supportive and Nutritional Care For Adults With Pancreatic Cancer: A Pilot Study. Co-author DOI 10.1016/j.jpainsymman.2025.07.032↗
  3. Lifetime stressor exposure and depression among patients with pancreatic cancer: insights from the Florida Pancreas Collaborative. Co-author DOI 10.1186/s12885-025-15007-w↗
  4. LOAd703 and chemotherapy combination in pancreatic cancer: insights from the LOKON001 study. First author DOI 10.21037/tgh-24-139↗
  5. A Rare Case of Simultaneous Brain and Leptomeningeal Metastases in a Patient With Pancreatic Cancer. Co-author DOI 10.7759/cureus.79923↗
  6. Support Through Remote Observation and Nutrition Guidance (STRONG), a digital health intervention to reduce malnutrition among pancreatic cancer patients: A st… First author DOI 10.1016/j.conctc.2024.101271↗
  7. PARP Inhibitors in Pancreatic Cancer with Homologous Recombination Repair Gene Mutations: A Single-Institution Experience. Last author DOI 10.3390/cancers16203447↗
  8. The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with implications for surgical centralization. Co-author DOI 10.1016/j.sopen.2023.02.001↗
  9. Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-control… Co-author DOI 10.1016/s1470-2045(23)00478-3↗
  10. Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma. Co-author DOI 10.18632/oncotarget.28508↗
  11. Review of Current Systemic Therapy and Novel Systemic Therapy for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/curroncol30060404↗
  12. Surgical approach to pancreaticoduodenectomy for pancreatic adenocarcinoma: uncomplicated ends justify the means. Co-author DOI 10.1007/s00464-021-08845-9↗
  13. Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in KRAS Wild-Type Pancreatic Cancer. Last author DOI 10.1200/po.20.00265↗

Closest collaborators

The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pamela Joy Hodul · 6 shared papers, 2022–2026 · strength 1.05
  2. Mokenge Peter Malafa · 6 shared papers, 2021–2026 · strength 0.93
  3. Jennifer B. Permuth · 4 shared papers, 2023–2026 · strength 0.75
  4. Sarah E. Hoffe · 4 shared papers, 2023–2026 · strength 0.68
  5. Jason B. Fleming · 4 shared papers, 2021–2023 · strength 0.61
  6. Nicole Nardella · 3 shared papers, 2024–2026 · strength 0.55
  7. Ziad Abuhelwa · 1 shared paper, 2025 · strength 0.54
  8. José M. Pimiento · 3 shared papers, 2022–2025 · strength 0.50
  9. Jason W. Denbo · 3 shared papers, 2022–2023 · strength 0.49
  10. Kea L. Turner · 2 shared papers, 2024–2025 · strength 0.35
  11. A. Alishani Tabriz · 2 shared papers, 2024–2025 · strength 0.35
  12. Daniel A. Anaya · 2 shared papers, 2022–2023 · strength 0.31
  13. Sarah Yahya Ali · 1 shared paper, 2025 · strength 0.30
  14. Omar Alzarkali · 1 shared paper, 2025 · strength 0.30
  15. Humaira Rise Sarfraz · 1 shared paper, 2023 · strength 0.26
  16. Ruoyu Miao · 1 shared paper, 2024 · strength 0.21
  17. Sophie Moravec · 1 shared paper, 2026 · strength 0.20
  18. Richard D. Kim · 1 shared paper, 2026 · strength 0.20
  19. Allan Andresson Lima Pereira · 1 shared paper, 2026 · strength 0.20
  20. Carmelo Blanquicett · 1 shared paper, 2026 · strength 0.20
  21. Daniel K. Jeong · 1 shared paper, 2025 · strength 0.19
  22. Anthony DeSomma · 1 shared paper, 2025 · strength 0.19
  23. Kun Jiang · 1 shared paper, 2025 · strength 0.19
  24. Vic Velanovich · 1 shared paper, 2025 · strength 0.19
  25. Mark Bloomston · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.